People on the Move
True North Therapeutics
True North Therapeutics, a drug developer focused on immunology and unmet needs, has appointed James Gilbert as the company’s first Chief Medical Officer (CMO).
Gilbert is a seasoned biopharmaceutical executive with experience moving early stage R&D programs through clinical development and commercialisation. He will report to True North’s CEO Nancy Stagliano and serve on the company’s executive management team.
Before joining True North, Gilbert was CMO at Cardioxyl and Archemix, and a consulting clinical advisor to several life science venture capital firms and private early-stage biotechnology companies.
True North recently announced a Series A financing which will be used to advance its lead drug candidate, TNT009, into clinical trials in early 2015 for autoantibody-driven rare diseases that are mediated by the Complement system.
